The ROE as of September 2024 (TTM) for Lipocine Inc. (LPCN) is -38.58%

According to Lipocine Inc.’s latest financial reports and current stock price. The company's current ROE is -38.58%. This represents a change of 280.15% compared to the average of -10.15% of the last 4 quarters.

Lipocine Inc. (LPCN) Historical ROE (quarterly & annually)

How has LPCN ROE performed in the past?

The mean historical ROE of Lipocine Inc. over the last ten years is -88.31%. The current -38.58% ROE has changed -56.32% with respect to the historical average. Over the past ten years (40 quarters), LPCN's ROE was at its highest in in the December 2021 quarter at 27.70%. The ROE was at its lowest in in the March 2020 quarter at -88.06%.

Lipocine Inc. (LPCN) ROE by Quarter and Year

Discovering the peaks and valleys of Lipocine Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipocine Inc. (LPCN) Average ROE

How has LPCN ROE performed in the past?

The current ROE of Lipocine Inc. (LPCN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lipocine Inc. (LPCN) ROE vs. Peers

How is LPCN’s ROE compared to its peers?

Lipocine Inc.’s ROE is greater than Sigilon Therapeutics, Inc. (-81.98%), less than Reviva Pharmaceuticals Holdings, Inc. (7.96%), greater than ZyVersa Therapeutics, Inc. (-172.51%), less than Kiromic BioPharma, Inc. (337.72%), less than Unicycive Therapeutics, Inc. (294.74%), less than Checkpoint Therapeutics, Inc. (292.43%), less than Mustang Bio, Inc. (1.40%), greater than Fortress Biotech, Inc. (-226.63%), greater than Kodiak Sciences Inc. (-77.23%), greater than Ardelyx, Inc. (-39.73%), greater than Zura Bio Limited (-35.45%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), less than AVROBIO, Inc. (29.68%), greater than Verastem, Inc. (-133.02%), less than Reviva Pharmaceuticals Holdings, Inc. (0%), less than Eyenovia, Inc. (7.96%), greater than Cognition Therapeutics, Inc. (-615.55%), greater than TransCode Therapeutics, Inc. (-118.11%), greater than null (-597.47%),

Build a custom stock screener for Lipocine Inc. (LPCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipocine Inc. (LPCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.